BDD Pharma opens brand new GMP manufacturing facility following £2m in funding

Leading contract research company BDD has opened its new 122m² GMP manufacturing facility at BioCity near Glasgow, following a successful inspection by the Medicines and Healthcare products Regulatory Authority (MHRA) in March 2025.

Two years in the making, the development of the state-of-the-art facility was facilitated by a funding round of £2 million from existing investors led by the world’s longest running angel investment syndicate, Archangels, with Scottish Enterprise and new investor, British Business Bank.

Read more HERE.